Similar oncologic efficacy for robotic, open cystectomy

December 21, 2012
Similar oncologic efficacy for robotic, open cystectomy
For patients with bladder cancer undergoing radical cystectomy, a robotic approach seems to have the same oncologic efficacy as an open approach and demonstrates potential perioperative benefits, according to a pilot study published in the February issue of The Journal of Urology.

(HealthDay)—For patients with bladder cancer undergoing radical cystectomy, a robotic approach seems to have the same oncologic efficacy as an open approach and demonstrates potential perioperative benefits, according to a pilot study published in the February issue of The Journal of Urology.

Dipen J. Parekh, M.D., from the University of Texas Health Sciences Center at San Antonio, and colleagues conducted a comparing the perioperative outcomes and oncologic efficacy of open and robotic assisted laparoscopic radical cystectomy. Data were available for 40 patients.

The researchers observed no significant differences between the groups with respect to the oncologic outcomes of positive margins (5 percent each) or the number of lymph nodes removed (23 for open radical cystectomy versus 11 for robotic assisted laparoscopic radical cystectomy; P = 0.135). The estimated blood loss was reduced for the robotic assisted laparoscopic radical cystectomy group (400 ml) compared with the open radical cystectomy group (800 ml). In addition, there was a trend toward a decreased rate of stays longer than five days in the robotic group (65 versus 90 percent; P = 0.11) as well as a trend toward fewer transfusions (40 versus 50 percent, P = 0.26).

"Our results suggest no significant differences in surrogates of oncologic efficacy. Robotic assisted laparoscopic radical cystectomy demonstrates potential benefits of decreased estimated blood loss and decreased hospital stay compared to open radical cystectomy," the authors write. "Our results need to be validated in a larger multicenter prospective ."

Explore further: Robotic-assisted radical bladder surgery potentially benefits bladder cancer patients

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Robotic-assisted radical bladder surgery potentially benefits bladder cancer patients

December 19, 2012
About 30 percent of the more than 70,000 bladder cancer cases expected in 2012 are muscle invasive. In such cases, radical cystectomy is the preferred treatment. In a pilot trial, a team of investigators assessed the efficacy ...

Prognosis after cystectomy not affected by smoking

October 15, 2012
(HealthDay)—Despite the link between cigarette smoking and the development of bladder cancer, the prognosis of people with bladder cancer after undergoing a cystectomy is not affected by cigarette smoking, according to ...

Fewer deaths, complications with robotic bladder cancer surgery, but cost is higher

April 2, 2012
With technological advancements opening the door to less invasive medical procedures, robotic-assisted surgery is becoming increasingly popular, despite being more expensive than traditional surgery. Robotic-assisted surgical ...

Post-radical cystectomy discharge patterns described

March 29, 2012
(HealthDay) -- In the past decade there has been a decrease in prolonged length of stay following radical cystectomy in the United States, while rates of transfer to a facility have remained stable, with insurance status ...

Advanced surgical approaches may benefit elderly patients with colorectal, bladder cancers

October 3, 2012
Advanced surgical techniques such as robotic-assisted operations and minimally invasive surgical procedures may extend survival and improve recovery in octogenarians with bladder and colorectal cancers when compared with ...

Rising eye injury rates seen with robotic prostate surgery

October 16, 2012
(HealthDay)—The number of eye injuries associated with robotic-assisted radical prostatectomy—complete removal of the prostate—increased nearly tenfold in the United States between 2000 and 2009, although the risk was ...

Recommended for you

Could a green sponge hold cancer-fighting secrets?

July 27, 2017
A small green sponge discovered in dark, icy waters of the Pacific off Alaska could be the first effective weapon against pancreatic cancer, researchers said on Wednesday.

Stem cell therapy attacks cancer by targeting unique tissue stiffness

July 26, 2017
A stem cell-based method created by University of California, Irvine scientists can selectively target and kill cancerous tissue while preventing some of the toxic side effects of chemotherapy by treating the disease in a ...

Understanding cell segregation mechanisms that help prevent cancer spread

July 26, 2017
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.

Study uncovers potential 'silver bullet' for preventing and treating colon cancer

July 26, 2017
In preclinical experiments, researchers at VCU Massey Cancer Center have uncovered a new way in which colon cancer develops, as well as a potential "silver bullet" for preventing and treating it. The findings may extend to ...

Compound shows promise in treating melanoma

July 26, 2017
While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward ...

Study may explain failure of retinoic acid trials against breast cancer

July 25, 2017
Estrogen-positive breast cancers are often treated with anti-estrogen therapies. But about half of these cancers contain a subpopulation of cells marked by the protein cytokeratin 5 (CK5), which resists treatment—and breast ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.